Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab.
Scarozza P, Marafini I, Laudisi F, Troncone E, Schmitt H, Lenti MV, Costa S, Rocchetti I, De Cristofaro E, Salvatori S, Frezzati L, Di Sabatino A, Atreya R, Neurath MF, Calabrese E, Monteleone G.
Scarozza P, et al. Among authors: troncone e.
J Clin Med. 2020 Feb 1;9(2):385. doi: 10.3390/jcm9020385.
J Clin Med. 2020.
PMID: 32024071
Free PMC article.